Home›Companies›Biotech & Pharma›NantBio

NantBio, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 13, 2023·Suggest an edit

About NantBio

NantBio is a private company based in El Segundo, California. It has reported $105,000,000 raised in four offerings on Form D since May 2014.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 29, 2015May 12, 2015amended Jun 2, 2015$10,000,000fully sold1$10.0MEquityRule 506(b)Form D/A ↗1 earlier filing
Jul 9, 2014Feb 6, 2015$45,000,000fully sold1$45.0MEquityRule 506(b)Form D ↗
Oct 24, 2014Oct 30, 2014$25,000,000of $100.0M target1$25.0MEquityRule 506(b)Form D ↗
Jan 2, 2014May 16, 2014$25,000,000fully sold1$25.0MEquityRule 506(b)Form D ↗
Total, four offerings$105,000,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on NantBio's Form D filed Jun 2, 2015.

PS
Patrick Shoon-Shiong
Director
First appears on the Form D that NantBio filed on February 6, 2015; on 3 of its 6 filings.

Earlier filings also listed

  • Patrick Soon-Shiong · president, chief executive officer and director
    Last listed on the Form D that NantBio filed on November 13, 2023; on 3 of its 6 filings.
  • James Banaag · chief financial officer
    Last listed on the Form D that NantBio filed on November 13, 2023; on 1 of its 6 filings.
  • Douglas Maughan · director
    Last listed on the Form D that NantBio filed on November 13, 2023; on 1 of its 6 filings.
  • Charles Kenworthy · secretary and director
    Last listed on the Form D that NantBio filed on November 13, 2023; on 1 of its 6 filings.

Sources

  1. SECNantBio, Inc. Form D, filed May 12, 2015
  2. SECNantBio, Inc. filing history